JACK ISAAC ZWEIG
Medical Practice in New Rochelle, NY
License number
Pennsylvania MD427768
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
New Rochelle, NY 10804
Pennsylvania
Pennsylvania
Personal information
See more information about JACK ISAAC ZWEIG at radaris.comName
Address
Phone
40 Park, New York, NY 10016
145 Vaneck Dr, New Rochelle, NY 10804
Professional information
Jack Zweig, New Rochelle NY
Work:
Murray Hill Medical Group
145 Vaneck Dr, New Rochelle, NY 10804 Murray Hill Medical Group
40 Park Ave, New York, NY 10016
145 Vaneck Dr, New Rochelle, NY 10804 Murray Hill Medical Group
40 Park Ave, New York, NY 10016
Dr. Jack I Zweig, New Rochelle NY - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
145 Ec Dr, New Rochelle 10804
(914) 235-0512 (Fax)
JACK I ZWEIG MD PC
145 Vaneck Dr, New Rochelle 10804
(914) 235-5990 (Phone), (914) 235-0512 (Fax)
(914) 235-0512 (Fax)
JACK I ZWEIG MD PC
145 Vaneck Dr, New Rochelle 10804
(914) 235-5990 (Phone), (914) 235-0512 (Fax)
Certifications:
Internal Medicine, 1973
Awards:
Healthgrades Honor Roll
Languages:
English, German
Education:
Medical School
New York Medical College
Graduated: 1963
Beth Israel Medical Center-Petrie Campus
Kings County Hospital Center
Memorial Sloan-Kettering Cancer Center
New York Medical College
Graduated: 1963
Beth Israel Medical Center-Petrie Campus
Kings County Hospital Center
Memorial Sloan-Kettering Cancer Center
Drug Activation By Radiation
US Patent:
4202323, May 13, 1980
Filed:
Apr 28, 1978
Appl. No.:
5/900897
Inventors:
Jack Zweig - New Rochelle NY
William McLaughlin - Washington DC
Matthew L. Herz - Framingham MA
William McLaughlin - Washington DC
Matthew L. Herz - Framingham MA
International Classification:
A61K 2900, A61B 1000
US Classification:
128 11
Abstract:
A method of selectively causing drug activation within a living body which comprises administering to a living body a polyamino arylmethylnitrile capable of undergoing controlled cleavage to form a polyaminoaryl methyl ion and/or a free cyanide ion, the drug also being soluble in the body serum so that it is capable of passing via oral, intramuscular or intra-peritoneal administration into a body, and then subjecting a localized area of said body to radiation capable of causing cleavage of the cyanide ion from the drug precursor, the resulting ions acting to sensitize the localized area to radiation.
Methods And Compositions For Treatment Of Prostate Intraepithelial Neoplasia
US Patent:
2011020, Aug 18, 2011
Filed:
Oct 14, 2006
Appl. No.:
12/083643
Inventors:
Jack I. Zweig - New Rochelle NY, US
Elizabeth Zweig - New Rochelle NY, US
Elizabeth Zweig - New Rochelle NY, US
International Classification:
A61K 31/40, A61K 31/192, A61P 35/00
US Classification:
514423, 514569
Abstract:
Provided herein are methods of treatment of prostate intraepithelial neoplasia (PIN) by administering bexarotene. Also provided are pharmaceutical compositions and dosing regimens.